NCT01094067 - Tezosentan in Patients With Pulmonary Arterial Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2010

Primary Completion Date

December 1, 2010

Study Completion Date

September 1, 2011

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

ACT-050089

5 mg/h intravenously, Tezosentan

OTHER

Placebo

Matching placebo

Trial Locations (5)

Baylor College of Medicine, Houston

Hopital Antoine Beclere, Clamart

Osaka University Hospital, Osaka

National Cardiovascular Center, Osaka

Keio University Hospital, Shinjuku-Ku